Confidential Investment Memorandum · 2026
The Body Has a System No One Has Commercialised at Scale. Until Now.
FasciaClinics is building a leading franchise network for fascia-based bodywork — a $6.8 trillion wellness market with no dominant player, no category leader, and no comparable exit in the last decade.
Investment Thesis
Proven model — 16 years of R&D, 100,000+ treatments, profitable franchise units
Proprietary technology — Atlasbalans, patented (EP2549972B1), German Design Award 2020
10-year head start — no competitor combines knowledge, technology, network, and brand
Asset-light expansion — franchisee bears operational risk, we earn royalties
International traction — Japan LLC formed April 2026, USA in preparation
Key Metrics
100,000+
Treatments delivered
16 yrs
R&D & clinical experience
500+
Certified specialists
1,126
Verified reviews (4.9 ★)
Proven in the World's Hardest Market
16 active clinics across Sweden. 1,126 verified reviews averaging 4.9 stars. Over 100,000 treatments delivered. This is not a concept — it is a running, profitable operation.
Swedish Fascia Convention 2025
Atlasbalans Treatment
The Gap in Modern Healthcare
Modern medicine has fragmented the body into specialities. No one sees the whole. Fascia — recently recognised as a distinct anatomical system (Stecco et al., Journal of Anatomy, 2025) — is the missing piece. Myofascial pain affects up to 85% of adults over a lifetime. Conditions like frozen shoulder, chronic pain, and restricted mobility remain poorly served by conventional approaches.
A Complete System — Not Just a Treatment
FasciaClinics delivers standardised fascia-based programs through a franchise network. Proprietary Atlasbalans technology, a reproducible protocol, and a plug-and-play franchise system enable rapid, quality-assured expansion.
Proprietary Technology
Atlasbalans
Patented treatment technology (EP2549972B1). German Design Award 2020. Good Design Award 2018. Over 1,200 units sold globally. Manufactured in Sweden.
Treatment Protocol
Standardised 6-step program. Measurable outcomes. Reproducible across clinics worldwide.
Franchise System
Plug-and-play model. Training, marketing, booking, and quality assurance built in.
Why Sweden Is the Proof
Sweden is internationally known as the world's hardest market. If a concept survives here, it works anywhere.
Spotify
Dismissed by labels
Klarna
Questioned by banks
King
Overlooked by VCs
We've been forged in the same fire for 16 years. FasciaClinics hasn't just survived — we've thrived.
International Expansion
From Swedish proof of concept to global scale. Two focus markets under active development.
Japan
FasciaClinics Japan LLC formed April 2026 — pilot clinic Izumo Q3/Q4 2026
United States
In preparation — market analysis complete, partner discussions initiated
The Business Model
Three recurring revenue streams. Asset-light. Globally scalable.
01
Royalty per treatment
Every treatment at every clinic worldwide generates a royalty to FasciaClinics International.
02
Unit startup fee
Upfront fee for each new franchise unit opened — covers training, onboarding, and system access.
03
Master franchise licence
Country-level licence fee for each new market — grants exclusive rights within defined territory.
Request Full Investment Documentation
This material is exclusively directed to qualified investors. Provide your details below to access the full investment memorandum, financial model, and supporting documentation.
No commitment required.